11-Aug-2026
Market Chameleon (Tue, 11-Aug 3:36 AM ET)
Globe Newswire (Mon, 10-Aug 12:56 PM ET)
AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law
Business Wire (Sat, 8-Aug 3:35 PM ET)
AdaptHealth Corp. to Participate in Upcoming Investor Conferences
Business Wire (Fri, 7-Aug 4:05 PM ET)
Business Wire (Fri, 7-Aug 10:07 AM ET)
Business Wire (Thu, 6-Aug 11:00 AM ET)
PRNewswire (Thu, 6-Aug 10:08 AM ET)
Business Wire (Thu, 6-Aug 9:00 AM ET)
Business Wire (Wed, 5-Aug 3:19 PM ET)
PRNewswire (Wed, 5-Aug 2:01 PM ET)
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.
Adapthealth Corp. trades on the NASDAQ stock market under the symbol AHCO.
As of August 11, 2026, AHCO stock price climbed to $5.65 with 4,843,441 million shares trading.
AHCO has a beta of -1.54, meaning it tends to be less sensitive to market movements. AHCO has a correlation of 0.06 to the broad based SPY ETF.
AHCO has a market cap of $753.76 million. This is considered a Small Cap stock.
Last quarter Adapthealth Corp. reported $740 million in Revenue and $.08 earnings per share. This fell short of revenue expectation by $-111 million and missed earnings estimates by -$.04.
In the last 3 years, AHCO traded as high as $14.06 and as low as $5.21.
The top ETF exchange traded funds that AHCO belongs to (by Net Assets): IJR, VTI, VB, VBR, IWM.
AHCO has underperformed the market in the last year with a price return of -38.5% while the SPY ETF gained +22.1%. AHCO has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -50.0% and -48.4%, respectively, while the SPY returned +4.7% and +4.3%, respectively.
AHCO support price is $5.04 and resistance is $5.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AHCO shares will trade within this expected range on the day.